Page 2 - Luke Selth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Luke selth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Luke Selth Today - Breaking & Trending Today

Researchers awarded $4.1 million in funding

Researchers awarded $4.1 million in funding
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Flinders University , South Australia , Ben Lohmeyer , Andrew Goldsmith , Robert Miller , Karin Nordstrom , Yvonne Clark , Stephanie Godfrey , Luke Selth , Jodie Lutkenhaus , Rong Zhu , Mark Halsey , Robert Phiddian , Thomas Hasel , Qin Li , Rob Manwaring , Terry Bertozzi , Damien Riggs , Ben Wadham , Mike Lee , Caitlin Hughes , Joanne Arciuli , Justin Chalker , Sally Robinson , Melanie Takarangi , Michael Gardner ,

Targeting prostate cancer metabolism

Targeting prostate cancer metabolism
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South Australia , University Of Adelaide , Flinders University , Luke Selth , Elisa Butler , Freemasons Centre For Male Health , Flinders Health , Research Institute , Australian Health , South Australian , Professor Luke Selth , Medical Research Institute , Freemasons Centre , Male Health , Professor Lisa Butler , South Australian Health ,

Novel prostate cancer resistance mechanism could be a promising target


Novel prostate cancer resistance mechanism could be a promising target
SHARES
in vitro.
Researchers have identified a new mechanism through which prostate cancer cells convert to a more aggressive subtype in response to hormonal therapies. According to the team, further exploration of their findings may enable scientists to develop more targeted ways to remedy treatment resistant prostate cancer, or even prevent its emergence.
The findings, published in 
Cell Reports, in part explain how an aggressive subtype of prostate cancer, called neuroendocrine prostate cancer (NEPC), develops as a result hormonal therapies.
There are currently no effective treatments for NEPC, as a result it has a very poor prognosis – a major issue, since as much as 15 percent of men may develop it in response to treatment. So, scientists are working to better understand what drives the development of NEPC in the hopes of preventing it. ....

Luke Selth , Flinders Health , Research Institute , Cell Reports , Associate Professor Luke Selth , Medical Research Institute , Professor Selth , ஃப்லிஂடர்‌ஸ் ஆரோக்கியம் , ஆராய்ச்சி நிறுவனம் , செல் அறிக்கைகள் , மருத்துவ ஆராய்ச்சி நிறுவனம் ,